Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 27, 2015 6:23 PM ET


Company Overview of Inhibitex, Inc.

Executive Profile

Erik De Clercq M.D., Ph.D.

Chairman of Scientific Advisory Board, Inhibitex, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Dr. Erik De Clercq, MD, PhD served as Professor Emeritus (active retired) at the Katholieke Universiteit Leuven, Belgium and President of the Rega Foundation (Rega Institut V.Z.W.). Dr. Clercq has been Chairman and Member of Scientific Advisory Board of Inhibitex, Inc. since November 2007. He has invented or co-invented a number of approved antivirals including tenofovir, one of the most widely-used drugs for the treatment of HIV AIDS.

Corporate Headquarters

9005 Westside Parkway
Alpharetta, Georgia 30009

United States

Phone: 678-746-1100
Fax: 678-746-1299

Board Members Memberships

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Inhibitex, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at